HER2-mediated modulation of PI3K/AKT signaling pathway activity not only plays a key role in promoting cell proliferation and inhibiting cell death, but has also been shown to mediate multidrug resistance in human breast cancer. This evidence concerns the gene AKT1 and breast carcinoma.